Home Compare EXAS vs NTRA
Stock Comparison · Industry comparison · Diagnostics & Research

Exact Sciences vs Natera: Which Stock Looks Stronger in 2026?

Natera holds the cleaner structural position, with the lead spread across growth and stability. The remaining gap is narrow enough that the comparison remains open to different readings. The market setup is broadly comparable for both — no clear directional signal from price behavior. The market is not adding a decisive signal either way — the structural read carries the weight.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The lead is spread across growth and stability, rather than sitting in one isolated gap.

INDUSTRY COMPARISON

Both operate in: Diagnostics & Research

This comparison is based on industry proximity, not on functional trajectory similarity. EXAS and NTRA share the same industry classification.

For a similarity-based comparison, see how Exact Sciences and Natera each position within their functional peer groups in AssetNext.

Peer-Relative Score
EXAS
Exact Sciences Corp
33
Peer-Score
Signal qualityHigh
vs
NTRA
Natera, Inc.
39
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

Score differences across key dimensions.

Dimension spread: EXAS vs NTRA Profitability 3 5 Stability 30 43 Valuation 33 30 Growth 83 100 EXAS NTRA
Gap Ranking
#1 Growth +17
#2 Stability +13
#3 Valuation +3
#4 Profitability +2
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for EXAS and NTRA Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer EXASNTRA Relative valuation Structural strength

Natera, Inc. still looks stronger, and the price setup does not materially undermine that lead.

Valuation position uses Forward P/E and peer-relative valuation score where available.

Relative Position vs Comparable Companies
Growth
Both are strong on growth, but Exact Sciences Corp still ranks higher.
Stability
Natera, Inc. holds the stronger peer position on stability.
Growth — Dominant Gap
EXAS
83
NTRA
100
Gap+17in favour of NTRA

The current lead is backed by a stronger multi-year growth trajectory.

What keeps the gap from being one-sided

Exact Sciences Corp still looks less cycle-sensitive — that keeps the result from looking completely one-sided.

What this means for the comparison

The lead is built on both growth and stability, making it broader than a single-dimension result.

Explore full peer positioning in AssetNext

Break down the EXAS vs NTRA comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar growth-and-stability comparisons

Explore how EXAS and NTRA each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.